Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Polymeric nanomaterials for islet targeting and immunotherapeutic delivery.

Ghosh K, Kanapathipillai M, Korin N, McCarthy JR, Ingber DE.

Nano Lett. 2012 Jan 11;12(1):203-8. doi: 10.1021/nl203334c. Epub 2011 Dec 28.

2.

Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.

Lopez-Talavera JC, Garcia-Ocaña A, Sipula I, Takane KK, Cozar-Castellano I, Stewart AF.

Endocrinology. 2004 Feb;145(2):467-74. Epub 2003 Oct 9.

PMID:
14551233
3.

Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells.

Barnett BP, Arepally A, Karmarkar PV, Qian D, Gilson WD, Walczak P, Howland V, Lawler L, Lauzon C, Stuber M, Kraitchman DL, Bulte JW.

Nat Med. 2007 Aug;13(8):986-91. Epub 2007 Jul 29.

PMID:
17660829
4.
5.

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.

Rabinovitch A, Suarez-Pinzon WL, Shapiro AM, Rajotte RV, Power R.

Diabetes. 2002 Mar;51(3):638-45.

6.

Human amniotic epithelial cells induce localized cell-mediated immune privilege in vitro: implications for pancreatic islet transplantation.

Qureshi KM, Oliver RJ, Paget MB, Murray HE, Bailey CJ, Downing R.

Cell Transplant. 2011;20(4):523-34. doi: 10.3727/096368910X528111. Epub 2010 Sep 30.

PMID:
20887662
7.

Low-dose rapamycin unmasks the protective potential of targeting intragraft NF-κB for islet transplants.

Zammit NW, Tan BM, Walters SN, Liuwantara D, Villanueva JE, Malle EK, Grey ST.

Cell Transplant. 2013;22(12):2355-66. doi: 10.3727/096368912X658737. Epub 2012 Oct 31.

PMID:
23127588
8.

Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion.

Wang Q, Uno T, Miyamoto Y, Hara Y, Kitazawa Y, Lu FZ, Funeshima N, Fujino M, Yamamoto H, Takenaka H, Kawashima Y, Li XK.

Am J Transplant. 2004 May;4(5):721-7.

9.

[Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines].

Balibrea del Castillo JM, Arias-Díaz J, García Martín MC, Vives-Pi M, García Pérez JC, Cantero Cid R, Vara Ameigeiras E, Balibrea Cantero JL.

Cir Esp. 2010 Jun;87(6):372-7. doi: 10.1016/j.ciresp.2010.03.009. Epub 2010 May 10. Spanish.

PMID:
20452578
10.

Pancreatic islet transplantation for treating diabetes.

Matsumoto S, Noguchi H, Yonekawa Y, Okitsu T, Iwanaga Y, Liu X, Nagata H, Kobayashi N, Ricordi C.

Expert Opin Biol Ther. 2006 Jan;6(1):23-37. Review.

PMID:
16370912
11.

Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.

Prasad KM, Yang Z, Bleich D, Nadler JL.

Gene Ther. 2000 Sep;7(18):1553-61.

12.

Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion.

Kizilel S, Scavone A, Liu X, Nothias JM, Ostrega D, Witkowski P, Millis M.

Tissue Eng Part A. 2010 Jul;16(7):2217-28. doi: 10.1089/ten.TEA.2009.0640.

PMID:
20163204
13.

Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.

Xin MJ, Cui SH, Liu S, Sun HC, Li F, Sun JB, Luo B.

Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):312-8.

14.

Transplantation of purified islet cells in diabetic rats. III. Immunosuppressive effect of cyclosporin.

Pipeleers-Marichal M, Ling ZD, Teng H, Pipeleers DG.

Diabetes. 1991 Jul;40(7):931-8.

PMID:
2060729
15.

Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.

Ludwig B, Barthel A, Reichel A, Block NL, Ludwig S, Schally AV, Bornstein SR.

Vitam Horm. 2014;95:195-222. doi: 10.1016/B978-0-12-800174-5.00008-9. Review.

PMID:
24559919
16.

The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.

Pavlovic D, Chen MC, Gysemans CA, Mathieu C, Eizirik DL.

Eur Cytokine Netw. 1999 Sep;10(3):403-12.

18.

Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts.

Shapiro AM, Geng Hao E, Lakey JR, Finegood DT, Rajotte RV, Kneteman NM.

Transplantation. 2002 Dec 15;74(11):1522-8.

PMID:
12490784
19.

Synergistic effect of surface modification with poly(ethylene glycol) and immunosuppressants on repetitive pancreatic islet transplantation into antecedently sensitized rat.

Jeong JH, Yook S, Hwang JW, Jung MJ, Moon HT, Lee DY, Byun Y.

Transplant Proc. 2013 Mar;45(2):585-90. doi: 10.1016/j.transproceed.2012.02.028. Epub 2012 Sep 15.

PMID:
23267798
20.

Application of polymeric nanoparticles in immunotherapy.

Craparo EF, Bondì ML.

Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):658-64. doi: 10.1097/ACI.0b013e3283588c57. Review.

PMID:
23095912

Supplemental Content

Support Center